These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1885424)

  • 1. The pharmacokinetics of cefuroxime axetil in the sick elderly patient.
    Ridgway E; Stewart K; Rai G; Kelsey MC; Bielawska C
    J Antimicrob Chemother; 1991 May; 27(5):663-8. PubMed ID: 1885424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of cefuroxime-axetil administered by the oral route in the elderly].
    Veyssier P; Darchis JP; Devillers A
    Therapie; 1988; 43 Suppl 4():355-9. PubMed ID: 3222776
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefuroxime axetil in the sick elderly patient.
    Cowling P; Case CP; MacGowan AP; Lovering AM; Humphreys H; Reeves DS; Madan I; Harding M; Harvey JE
    J Antimicrob Chemother; 1992 Mar; 29(3):350-1. PubMed ID: 1592706
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of cefuroxime axetil suspension in infants and children.
    Powell DA; James NC; Ossi MJ; Nahata MC; Donn KH
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2042-5. PubMed ID: 1759825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections.
    Cooper TJ; Ladusans E; Williams PE; Polychronopoulos V; Gaya H; Rudd RM
    J Antimicrob Chemother; 1985 Sep; 16(3):373-8. PubMed ID: 4055545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
    Lang CC; Moreland TA; Davey PG
    J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.
    Adams DH; Wood MJ; Farrell ID; Fox C; Ball AP
    J Antimicrob Chemother; 1985 Sep; 16(3):359-66. PubMed ID: 4055543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children.
    Kornberg AE; Sherin K; Veiga P; Mydlow PK; Collins JJ; Feld LG
    Am J Nephrol; 1994; 14(3):169-72. PubMed ID: 7977475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative investigations on the bioavailability of cefuroxime axetil.
    Kees F; Lukassek U; Naber KG; Grobecker H
    Arzneimittelforschung; 1991 Aug; 41(8):843-6. PubMed ID: 1781808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ; Ormrod D; Goa KL
    Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing kinetics of cefuroxime axetil against Haemophilus influenzae in an in-vitro model simulating serum concentration profiles after oral administration.
    Bingen E; Lambert-Zechovsky N; Doit C; Duvignaud P; Georges D; Mariani-Kurkdjian P
    J Antimicrob Chemother; 1991 Oct; 28(4):533-6. PubMed ID: 1761448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
    Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue penetration following orally administered cefuroxime axetil.
    Wise R
    J Chemother; 1989 Jul; 1(4 Suppl):515-6. PubMed ID: 16312510
    [No Abstract]   [Full Text] [Related]  

  • 15. A bioequivalence study of the cefuroxime axetil in healthy volunteers.
    Rojanasthien N; Boonchaliew C; Kumsorn B; Sangdee C
    J Med Assoc Thai; 2003 Nov; 86(11):1063-72. PubMed ID: 14696789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM; Brogden RN
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of cefuroxime into bronchial mucosa following oral administration of cefuroxime axetil.
    Winter J; Dhillon P
    J Antimicrob Chemother; 1991 Apr; 27(4):556-8. PubMed ID: 1856136
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
    Brink HS; Huisman RM; Geerlings W; de Jong PE
    Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor].
    Pariente R; Rochemaure J; Murciano D; Brechot JM; Pappo M
    Therapie; 1988; 43 Suppl 4():361-4. PubMed ID: 3222777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.